Ideaya Biosciences Inc (IDYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 207,834 | 0 | 0 | 0 | 0 |
| Gross Profit | 207,834 | N/A | N/A | N/A | N/A |
| Operating Expenses | 99,382 | 88,806 | 84,389 | 151,138 | 66,893 |
| Operating Income | 108,452 | -88,806 | -84,389 | -144,138 | -66,893 |
| Other Income | 10,792 | 11,315 | 12,211 | 13,826 | 15,072 |
| Pre-tax Income | 119,244 | -77,491 | -72,178 | -130,312 | -51,821 |
| Net Income Continuous | 119,244 | -77,491 | -72,178 | -130,312 | -51,821 |
| Net Income | $119,244 | $-77,491 | $-72,178 | $-130,312 | $-51,821 |
| EPS Basic Total Ops | 1.35 | -0.88 | -0.82 | -1.55 | -0.60 |
| EPS Basic Continuous Ops | 1.35 | -0.88 | -0.82 | -1.56 | -0.60 |
| EPS Diluted Total Ops | 1.33 | -0.88 | -0.82 | -1.55 | -0.60 |
| EPS Diluted Continuous Ops | 1.33 | -0.88 | -0.82 | -1.56 | -0.60 |
| EPS Diluted Before Non-Recurring Items | 1.33 | -0.88 | -0.82 | -1.49 | -0.60 |
| EBITDA(a) | $107,500 | $-90,265 | $-87,034 | $-155,411 | $-71,244 |